ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (“Ambry”) today publishes data in The Journal of Molecular Diagnostics from the largest study to date 1, 20,000 cases submitted for hereditary ...

Across clinical oncology applications, from molecular testing to cancer research, the ability to identify potentially actionable genomic and genetic alterations to exploit the molecular ...

[more than 13% of patients with advanced NSCLC and an aSV] "would have experienced a meaningful delay of several weeks or more if RNA-NGS and DNA-NGS had been performed sequentially rather than ...

Next-generation sequencing (NGS) multigene panel testing has become widespread, including the Veterans Affairs (VA), through the VA National Precision Oncology Program (NPOP). The interpretation of ...

ROCKVILLE, Md. – May 18, 2023 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, has published a report that was designed to establish ...

Dr. Peng Zhiyu, Vice President of BGI Genomics, recently emphasized that Thalassemia is highly preventable with carrier screening tests using Next-Generation Sequencing (NGS) technology. The speech ...

The partnership between OGT and QIAGEN Digital Insights (QDI), expands OGT’s bioinformatics capabilities by integrating QIAGEN’s advanced tertiary analysis solution, QCI Interpret, with its SureSeq™ ...

Join this webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer researchers today. Additionally, Dr ...

The past decade has seen accelerated discovery of the causal genes underlying Mendelian and complex diseases as well as progress toward the goal of personalized medicine. Technological achievements ...

Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) - the SureSeq™ Myeloid MRD Plus NGS Panel. Designed using OGT’s 30 years of ...